NCT00193414View on ClinicalTrials.gov

Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

August 31, 2009

Conditions
Lung Cancer
Interventions
DRUG

Pemetrexed

500mg/m2 IV over 10 min, Day 1, prior to gemcitabine

DRUG

Gemcitabine

1500mg/m2, 30min IV

Trial Locations (1)

37203

Tennessee Oncology, Nashville

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER

NCT00193414 - Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter